{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:23:17Z","timestamp":1793193797941,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Xi'an Science and Technology Plan Project Medical Research Project: General Research","award":["No.22YXYJ0134"],"award-info":[{"award-number":["No.22YXYJ0134"]}]},{"name":"Xi'an Science and Technology Plan Project Medical Research Project: General Research","award":["No.22YXYJ0134"],"award-info":[{"award-number":["No.22YXYJ0134"]}]},{"name":"Xi'an Science and Technology Plan Project Medical Research Project: General Research","award":["No.22YXYJ0134"],"award-info":[{"award-number":["No.22YXYJ0134"]}]},{"name":"Xi'an Science and Technology Plan Project Medical Research Project: General Research","award":["No.22YXYJ0134"],"award-info":[{"award-number":["No.22YXYJ0134"]}]},{"name":"Xi'an Science and Technology Plan Project Medical Research Project: General Research","award":["No.22YXYJ0134"],"award-info":[{"award-number":["No.22YXYJ0134"]}]},{"name":"General Project of Key R&D Program in Shaanxi Province\u2014Social Development Field","award":["No.2023-YBSF-631"],"award-info":[{"award-number":["No.2023-YBSF-631"]}]},{"name":"General Project of Key R&D Program in Shaanxi Province\u2014Social Development Field","award":["No.2023-YBSF-631"],"award-info":[{"award-number":["No.2023-YBSF-631"]}]},{"name":"General Project of Key R&D Program in Shaanxi Province\u2014Social Development Field","award":["No.2023-YBSF-631"],"award-info":[{"award-number":["No.2023-YBSF-631"]}]},{"name":"General Project of Key R&D Program in Shaanxi Province\u2014Social Development Field","award":["No.2023-YBSF-631"],"award-info":[{"award-number":["No.2023-YBSF-631"]}]},{"name":"General Project of Key R&D Program in Shaanxi Province\u2014Social Development Field","award":["No.2023-YBSF-631"],"award-info":[{"award-number":["No.2023-YBSF-631"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11443-9","type":"journal-article","created":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T09:44:55Z","timestamp":1767433495000},"page":"5449-5471","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Uncovering the antiproliferative effects of magnolol in liver cancer: a multi-omics study integrating computational chemistry, network pharmacology, bioinformatics and in vitro experimental validations"],"prefix":"10.1007","volume":"30","author":[{"given":"Yu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fende","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8156-9104","authenticated-orcid":false,"given":"Xiaojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"issue":"2","key":"11443_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3350\/cmh.2023.0070","volume":"29","author":"JH Oh","year":"2023","unstructured":"Oh JH, Jun DW (2023) The latest global burden of liver cancer: a past and present threat. Clin Mol Hepatol 29(2):355","journal-title":"Clin Mol Hepatol"},{"issue":"6","key":"11443_CR2","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","volume":"77","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77(6):1598\u20131606","journal-title":"J Hepatol"},{"issue":"5","key":"11443_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1159\/000530495","volume":"12","author":"J Zhou","year":"2023","unstructured":"Zhou J, Sun H, Wang Z, Cong W, Zeng M, Zhou W, Bie P, Liu L, Wen T, Kuang M, Han G (2023) Guidelines for the diagnosis and treatment of primary liver cancer (2022 edition). Liver Cancer 12(5):405\u2013444","journal-title":"Liver Cancer"},{"issue":"11","key":"11443_CR4","doi-asserted-by":"publisher","first-page":"e2447995","DOI":"10.1001\/jamanetworkopen.2024.47995","volume":"7","author":"KR Patel","year":"2024","unstructured":"Patel KR, Menon H, Patel RR, Huang EP, Verma V, Escorcia FE (2024) Locoregional therapies for hepatocellular carcinoma: a systematic review and Meta-Analysis. JAMA Netw Open 7(11):e2447995","journal-title":"JAMA Netw Open"},{"issue":"1","key":"11443_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s13659-020-00293-7","volume":"11","author":"M Huang","year":"2021","unstructured":"Huang M, Lu JJ, Ding J (2021) Natural products in cancer therapy: past, present and future. Nat Prod Bioprospect 11(1):5\u201313","journal-title":"Nat Prod Bioprospect"},{"key":"11443_CR6","doi-asserted-by":"publisher","first-page":"113054","DOI":"10.1016\/j.biopha.2022.113054","volume":"150","author":"S Hashem","year":"2022","unstructured":"Hashem S, Ali TA, Akhtar S, Nisar S, Sageena G, Ali S, Al-Mannai S, Therachiyil L, Mir R, Elfaki I, Mir MM (2022) Targeting cancer signaling pathways by natural products: exploring promising anti-cancer agents. Biomed Pharmacother 150:113054","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"11443_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.31083\/j.fbl2706192","volume":"27","author":"Y Wang","year":"2022","unstructured":"Wang Y, Chen M, Yu H, Yuan G, Luo L, Xu X, Xu Y, Sui X, Leung EL, Wu Q (2022) The role and mechanisms of action of natural compounds in the prevention and treatment of cancer and cancer metastasis. Front Biosci Landmark 27(6):192","journal-title":"Front Biosci Landmark"},{"issue":"3","key":"11443_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1080\/01635581.2021.1931364","volume":"74","author":"S Mottaghi","year":"2022","unstructured":"Mottaghi S, Abbaszadeh H (2022) Natural lignans Honokiol and Magnolol as potential anticarcinogenic and anticancer agents. A comprehensive mechanistic review. Nutr Cancer 74(3):761\u2013778","journal-title":"Nutr Cancer"},{"key":"11443_CR9","doi-asserted-by":"publisher","first-page":"114524","DOI":"10.1016\/j.jep.2021.114524","volume":"281","author":"L Niu","year":"2021","unstructured":"Niu L, Hou Y, Jiang M, Bai G (2021) The rich Pharmacological activities of Magnolia officinalis and secondary effects based on significant intestinal contributions. J Ethnopharmacol 281:114524","journal-title":"J Ethnopharmacol"},{"key":"11443_CR10","doi-asserted-by":"publisher","first-page":"117493","DOI":"10.1016\/j.indcrop.2023.117493","volume":"205","author":"J Xu","year":"2023","unstructured":"Xu J, Xu H (2023) Magnolol: chemistry and biology. Ind Crops Prod 205:117493","journal-title":"Ind Crops Prod"},{"issue":"19","key":"11443_CR11","doi-asserted-by":"publisher","first-page":"6441","DOI":"10.3390\/molecules27196441","volume":"27","author":"X Wang","year":"2022","unstructured":"Wang X, Liu Q, Fu Y, Ding RB, Qi X, Zhou X, Sun Z, Bao J (2022) Magnolol as a potential anticancer agent: a proposed mechanistic insight. Molecules 27(19):6441","journal-title":"Molecules"},{"key":"11443_CR12","doi-asserted-by":"publisher","first-page":"632767","DOI":"10.3389\/fphar.2021.632767","volume":"12","author":"Y Lin","year":"2021","unstructured":"Lin Y, Li Y, Zeng Y, Tian B, Qu X, Yuan Q, Song Y (2021) Pharmacology, toxicity, bioavailability, and formulation of magnolol: an update. Front Pharmacol 12:632767","journal-title":"Front Pharmacol"},{"issue":"4","key":"11443_CR13","first-page":"791","volume":"7","author":"H Tandon","year":"2019","unstructured":"Tandon H, Chakraborty T, Suhag V (2019) A brief review on importance of DFT in drug design. Res Med Eng Sci 7(4):791\u2013795","journal-title":"Res Med Eng Sci"},{"key":"11443_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.commatsci.2018.03.038","volume":"150","author":"W Taouali","year":"2018","unstructured":"Taouali W, Casida ME, Darghouth AA, Alimi K (2018) Theoretical design of new small molecules with a low band-gap for organic solar cell applications: DFT and TD-DFT study. Comput Mater Sci 150:54\u201361","journal-title":"Comput Mater Sci"},{"issue":"2","key":"11443_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt HH (2022) Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci 43(2):136\u2013150","journal-title":"Trends Pharmacol Sci"},{"issue":"5","key":"11443_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/ph15050572","volume":"15","author":"F Noor","year":"2022","unstructured":"Noor F, Tahir ul Qamar M, Ashfaq UA, Albutti A, Alwashmi AS, Aljasir MA (2022) Network Pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals 15(5):572","journal-title":"Pharmaceuticals"},{"key":"11443_CR17","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","volume":"60","author":"F Stanzione","year":"2021","unstructured":"Stanzione F, Giangreco I, Cole JC (2021) Use of molecular Docking computational tools in drug discovery. Prog Med Chem 60:273\u2013343","journal-title":"Prog Med Chem"},{"key":"11443_CR18","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.3389\/fonc.2020.01319","volume":"10","author":"CY Chen","year":"2020","unstructured":"Chen CY, Fang JY, Chen CC, Chuang WY, Leu YL, Ueng SH, Wei LS, Cheng SF, Hsueh C, Wang TH (2020) 2-O-methylmagnolol, a Magnolol derivative, suppresses hepatocellular carcinoma progression via inhibiting class i histone deacetylase expression. Front Oncol 10:1319","journal-title":"Front Oncol"},{"issue":"6","key":"11443_CR19","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.21873\/invivo.11387","volume":"32","author":"LY Kuan","year":"2018","unstructured":"Kuan LY, Chen WL, Chen JH, Hsu FT, Liu TT, Chen WT, Wang KL, Chen WC, Liu YC, Wang WS (2018) Magnolol induces apoptosis and inhibits ERK-modulated metastatic potential in hepatocellular carcinoma cells. In vivo 32(6):1361\u20131361","journal-title":"In vivo"},{"issue":"6512","key":"11443_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/373303a0","volume":"373","author":"G Ghosh","year":"1995","unstructured":"Ghosh G, Duyne GV, Ghosh S, Sigler PB (1995) Structure of NF-\u03baB p50 homodimer bound to a \u03baB site. Nature 373(6512):303\u2013310","journal-title":"Nature"},{"issue":"2","key":"11443_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.str.2012.11.014","volume":"21","author":"KS Gajiwala","year":"2013","unstructured":"Gajiwala KS, Feng J, Ferre R, Ryan K, Brodsky O, Weinrich S, Kath JC, Stewart A (2013) Insights into the aberrant activity of mutant EGFR kinase domain and drug recognition. Structure 21(2):209\u2013219","journal-title":"Structure"},{"issue":"21","key":"11443_CR22","doi-asserted-by":"publisher","first-page":"18756","DOI":"10.1074\/jbc.M110.206193","volume":"286","author":"K Aertgeerts","year":"2011","unstructured":"Aertgeerts K, Skene R, Yano J, Sang BC, Zou H, Snell G, Jennings A, Iwamoto K, Habuka N, Hirokawa A, Ishikawa T (2011) Structural analysis of the mechanism of Inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem 286(21):18756\u201318765","journal-title":"J Biol Chem"},{"issue":"22","key":"11443_CR23","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.3390\/ijms21228470","volume":"21","author":"KM Pflug","year":"2020","unstructured":"Pflug KM, Sitcheran R (2020) Targeting NF-\u03baB-inducing kinase (NIK) in immunity, inflammation, and cancer. Int J Mol Sci 21(22):8470","journal-title":"Int J Mol Sci"},{"key":"11443_CR24","doi-asserted-by":"crossref","unstructured":"Levantini E, Maroni G, Del Re M, Tenen DG (2022) EGFR signaling pathway as therapeutic target in human cancers. In: Seminars in cancer biology (Vol. 85, pp. 253\u2013275). Academic Press","DOI":"10.1016\/j.semcancer.2022.04.002"},{"issue":"10","key":"11443_CR25","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1038\/ncb3031","volume":"16","author":"H Lanaya","year":"2014","unstructured":"Lanaya H, Natarajan A, Komposch K, Li L, Amberg N, Chen L, Wculek SK, Hammer M, Zenz R, Peck-Radosavljevic M, Sieghart W (2014) EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation. Nat Cell Biol 16(10):972\u2013981","journal-title":"Nat Cell Biol"},{"key":"11443_CR26","doi-asserted-by":"publisher","first-page":"109090","DOI":"10.1016\/j.cbi.2020.109090","volume":"324","author":"B Bhushan","year":"2020","unstructured":"Bhushan B, Michalopoulos GK (2020) Role of epidermal growth factor receptor in liver injury and lipid metabolism: emerging new roles for an old receptor. Chemico-Biol Interact 324:109090","journal-title":"Chemico-Biol Interact"},{"issue":"12","key":"11443_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jamaoncol.2021.3595","volume":"7","author":"P Tarantino","year":"2021","unstructured":"Tarantino P, Modi S, Tolaney SM, Cort\u00e9s J, Hamilton EP, Kim SB, Toi M, Andr\u00e8 F, Curigliano G (2021) Interstitial lung disease induced by anti-ERBB2 antibody-drug conjugates: a review. JAMA Oncol 7(12):1873\u20131881","journal-title":"JAMA Oncol"},{"issue":"4","key":"11443_CR28","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.3892\/ijo.2011.1277","volume":"40","author":"A Rasul","year":"2012","unstructured":"Rasul A, Yu B, Khan M, Zhang K, Iqbal F, Ma T, Yang H (2012) Magnolol, a natural compound, induces apoptosis of SGC-7901 human gastric adenocarcinoma cells via the mitochondrial and PI3K\/Akt signaling pathways. Int J Oncol 40(4):1153\u20131161","journal-title":"Int J Oncol"},{"key":"11443_CR29","doi-asserted-by":"publisher","first-page":"114460","DOI":"10.1016\/j.comptc.2023.114460","volume":"1232","author":"J Sharanya","year":"2024","unstructured":"Sharanya J, Purushothaman A, Janardanan D, Koley K (2024) Theoretical exploration of the antioxidant activity of Honokiol and Magnolol. Comput Theor Chem 1232:114460","journal-title":"Comput Theor Chem"},{"issue":"8","key":"11443_CR30","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.3390\/ijms19082362","volume":"19","author":"AM Ranaware","year":"2018","unstructured":"Ranaware AM, Banik K, Deshpande V, Padmavathi G, Roy NK, Sethi G, Fan L, Kumar AP, Kunnumakkara AB (2018) Magnolol: a neolignan from the Magnolia family for the prevention and treatment of cancer. Int J Mol Sci 19(8):2362","journal-title":"Int J Mol Sci"},{"issue":"2","key":"11443_CR31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3390\/medicina59020286","volume":"59","author":"M Naghashpour","year":"2023","unstructured":"Naghashpour M, Dayer D, Karami H, Naghashpour M, Moghadam MT, Haeri SM Suzuki K (2023) Evaluating the magnolol anticancer potential in MKN-45 gastric cancer cells. Medicina 59(2):286","journal-title":"Medicina"},{"issue":"5","key":"11443_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1271\/bbb.90785","volume":"74","author":"ES Hwang","year":"2010","unstructured":"Hwang ES, Park KK (2010) Magnolol suppresses metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2\/-9 activities in PC-3 human prostate carcinoma cells. Biosci Biotechnol Biochem. 74(5):961\u2013967","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"11443_CR33","first-page":"94","volume":"16","author":"Y Chen","year":"2024","unstructured":"Chen Y, Chen S, Chen K, Ji L, Cui S (2024) Magnolol and 5-fluorouracil synergy Inhibition of metastasis of cervical cancer cells by targeting PI3K\/AKT\/mTOR and EMT pathways. Chin Herb Med 16(1):94\u2013105","journal-title":"Chin Herb Med"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11443-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11443-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:39:28Z","timestamp":1783161568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11443-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["11443"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11443-9","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}